23 May 2013
Keywords: pfizer, defends, celebrex, safety, shares, drug, major
Article | 15 November 2004
Shares in US drug major Pfizer fell after a Canadian newspaper reported that the firm's Celebrex (celecoxib), the best-selling COX-2 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 November 2004
8 November 2004
22 November 2004
© 2013 thepharmaletter.com